Month: May 2018

ViruCure to attend the Biotechnology Innovation Organization, 4-7 June, Boston, USA

May 31, 2018August 2, 2018

Come and meet with our CEO & Co-founder, Yoram Drucker at BIO 2018 to learn more about ViruCure’s breakthrough NADAV technology to fight cancer.

Learn More

Categories news

Search for:

Contact Us

info@virucure.com

ViruCure Therapeutics

ViruCure Therapeutics is a biotech company that is developing an oncolytic-virus-based technology platform, NADAV, for the targeted treatment of a wide range of cancers.